Zobrazeno 1 - 10 of 89 pro vyhledávání: '"J.E. Dankert-Roelse"'
1
Akademický článek
Parental knowledge reduces long term anxiety induced by false-positive test results after newborn screening for cystic fibrosis
Autor: A.M.M. Vernooij-van Langen, S.M. van der Pal, A.J.T. Reijntjens, J.G. Loeber, E. Dompeling, J.E. Dankert-Roelse
Publikováno v: Molecular Genetics and Metabolism Reports, Vol 1, Iss C, Pp 334-344 (2014)
Background: False-positive screening results in newborn screening for cystic fibrosis may lead to parental stress, family relationship problems and a changed perception of the child's health. Aim of the study: To evaluate whether parental anxiety ind
Externí odkaz: https://doaj.org/article/fb249ebf72fe4e2486d4cc534e32512e
Zobrazit plný text záznamu
2
Newborn blood spot screening for cystic fibrosis with a four-step screening strategy in the Netherlands
Autor: Karin M. de Winter-de Groot, Hettie M. Janssens, Johan J.P. Gille, J.E. Dankert-Roelse, Rendelien K. Verschoof-Puite, Bernadette S. Jakobs, Yvonne Schönbeck, Marelle J. Bouva, Vincent Gulmans, Paul H. Verkerk, Peter C. J. I. Schielen
Publikováno v: Dankert-Roelse, J E, Bouva, M J, Jakobs, B S, Janssens, H M, de Winter-de Groot, K M, Schönbeck, Y, Gille, J J P, Gulmans, V A M, Verschoof-Puite, R K, Schielen, P C J I & Verkerk, P H 2019, ' Newborn blood spot screening for cystic fibrosis with a four-step screening strategy in the Netherlands ', Journal of Cystic Fibrosis, vol. 18, no. 1, pp. 54-63 . https://doi.org/10.1016/j.jcf.2018.07.008
Journal of Cystic Fibrosis, 18, 54-63
Journal of Cystic Fibrosis, 18(1), 54-63. Elsevier
Background: Newborn screening for cystic fibrosis (NBSCF) was introduced in the Dutch NBS program in 2011 with a novel strategy. Methods: Dutch NBSCF consisted of four steps: immuno-reactive trypsin (IRT), Pancreatitis-associated Protein (PAP), DNA a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::710ac096c80326fe980a71dc5a46f73c
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85052059224&origin=inward
Zobrazit plný text záznamu
3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
4
The expansion and performance of national newborn screening programmes for cystic fibrosis in Europe
Autor: Carlo Castellani, J.E. Dankert-Roelse, Dorota Sands, Sarah Mayell, Simon Pybus, Kevin W Southern, Nataliya Kashirskaya, Barry Linnane, Anne Munck, Silvia Gartner, Victoria Winters, Olaf Sommerburg, Jürg Barben
Publikováno v: JOURNAL OF CYSTIC FIBROSIS
Background Newborn screening (NBS) for cystic fibrosis (CF) is a well-established public health strategy with international standards. The aim of this study was to provide an update on NBS for CF in Europe and assess performance against the standards
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de678a9bc40e817120bf561311c02874
https://doi.org/10.1016/j.jcf.2016.12.012
Zobrazit plný text záznamu
5
Clinical evaluation of the Nanoduct sweat test system in the diagnosis of cystic fibrosis after newborn screening
Autor: Edward Dompeling, Jan-Bart L. Yntema, J.E. Dankert-Roelse, Annette M. M. Vernooij-van Langen, Harm A.W.M. Tiddens, Bert G M Arets, Gerard Loeber
Publikováno v: European Journal of Pediatrics, 174(8), 1025-1034. Springer, Cham
European Journal of Pediatrics, 174(8), 1025. Springer Verlag
European Journal of Pediatrics, 174(8), 1025-1034. Springer-Verlag
After a positive newborn screening test for cystic fibrosis (CF), a sweat test is performed to confirm the diagnosis. The success rate of the generally acknowledged methods (Macroduct/Gibson and Cooke) in newborns varies between 73 and 99 %. The Nano
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62331f817936466164d48fb76ae32510
https://doi.org/10.1007/s00431-015-2501-0
Zobrazit plný text záznamu
6
Differences in clinical condition and genotype at time of diagnosis of cystic fibrosis by newborn screening or by symptoms
Autor: F.L.G.R. Gerzon, J.G. Loeber, Edward Dompeling, J.E. Dankert-Roelse, A.M.M. Vernooij-van Langen
Publikováno v: Molecular Genetics and Metabolism, 113(1-2), 100-104. Academic Press Inc.
Background: Early diagnosis through newborn screening (NBS) and early treatment of cystic fibrosis (CF) do lead to better prognosis. In the Netherlands, the median age for a clinical diagnosis is six months, and after newborn screening this is 30 day
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::672e72887629496001826c1de9adcd01
https://cris.maastrichtuniversity.nl/en/publications/79e28ac7-8b4b-4e18-af61-5f682e21d8c1
Zobrazit plný text záznamu
7
Newborn screening for cystic fibrosis: pros and cons
Autor: A. Vernooij-van Langen, J.E. Dankert-Roelse
Publikováno v: Breathe. :24-30
Educational aims To give an insight into the arguments that have led to the implementation of newborn screening for cystic fibrosis in routine screening programmes. To understand the drawbacks specifically associated with newborn screening for cystic
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::edd64c48a0d13a4e9789e4b3a7e134de
https://doi.org/10.1183/20734735.004111
Zobrazit plný text záznamu
8
Cochrane review: Newborn screening for cystic fibrosis
Autor: Marieke M. E. Mérelle, Kevin W Southern, A. F. Nagelkerke, J.E. Dankert-Roelse
Publikováno v: Evidence-Based Child Health: A Cochrane Review Journal. 4:1740-1773
Background Does newborn screening for cystic fibrosis (CF) improve clinical outcomes, quality of life and survival? Objectives To examine whether newborn screening for CF prevents or reduces irreversible organ damage and improves clinical outcomes, q
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6ce387a7805e1d5dd0813d3d0884ecd4
https://doi.org/10.1002/ebch.463
Zobrazit plný text záznamu
10
A survey of newborn screening for cystic fibrosis in Europe
Autor: Rodney J. Pollitt, Georges Travert, Kevin W Southern, Anne Munck, Luisa Zanolla, Carlo Castellani, J.E. Dankert-Roelse
Publikováno v: Journal of Cystic Fibrosis. 6:57-65
Background Cystic fibrosis (CF) is a recessively inherited condition caused by mutation of the CFTR gene. Newborn infants with CF have raised levels of immuno-reactive trypsinogen (IRT) in their serum. Measurement of IRT in the first week of life has
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cbc01076a47a3388e21ff8d63125e1d
https://doi.org/10.1016/j.jcf.2006.05.008
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje